Indication

Symptomatic treatment of myotonia in adult patients with non-dystrophic myotonic disorders.

Medicine details

Medicine name:
mexiletine (Namuscla)
SMC ID:
SMC2307
Pharmaceutical company
Lupin Healthcare
BNF chapter
Central nervous system
Submission type
Resubmission
Publication due date:
07 December 2020
SMC meeting date:
03 November 2020